Home Cart Sign in  
Chemical Structure| 1421854-16-1 Chemical Structure| 1421854-16-1

Structure of AC-186
CAS No.: 1421854-16-1

Chemical Structure| 1421854-16-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

AC 186 is a potent and selective ERβ agonist with EC50 of 6 nM.

Synonyms: AC-186

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of AC-186

CAS No. :1421854-16-1
Formula : C18H17F3O
M.W : 306.32
SMILES Code : FC1(F)CCC(C2=C(F)C=CC=C2)(C3=CC=C(O)C=C3)CC1
Synonyms :
AC-186
MDL No. :MFCD28502295
InChI Key :HSMUKSLNDJOZQG-UHFFFAOYSA-N
Pubchem ID :71245042

Safety of AC-186

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00289380 - Recruiting January 2020 China, Beijing ... More >> Beijing Friendship Hospital, Capital Medical University Active, not recruiting Beijing, Beijing, China, 100730 Peking Union Medical College Hospital Active, not recruiting Beijing, Beijing, China, 100730 China, Chongqing Chongqing Medical Univ. Hospital Completed Chongqing, Chongqing, China Xin Qiao Hospital Recruiting Chongqing, Chongqing, China Contact: Hua Yang, M.D.    +86 13668057773    hyang@med.umich.edu    Principal Investigator: Hua Yang, M.D.          China, Guangdong The First Affiliated Hospital, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510080 Contact: Wen-hua Zhan, M.D.    +86 20 87755766    wenhuazhan@medmail.com.cn    Principal Investigator: Wen-hua Zhan, M.D.          Sub-Investigator: Xiao-qing Liu, M.D.          China, Guangxi The First Affiliated Hospial, Guangxi Medical University Recruiting Nanning, Guangxi, China, 530021 Contact: Ning Xia, M.D.    +86 771 5303201       Principal Investigator: Ning Xia, M.D.          China, Hebei The First University Hospital, Hebei Medical University Recruiting Shijiazhuang, Hebei, China, 050031 Contact: Ru-mei Jia, M.D.    +86 311 85917000    jiarm@jyyy.com.cn    Principal Investigator: Ru-mei Jia, M.D.          Nankai Hospital Active, not recruiting Tianjin, Hebei, China, 300100 China, Hubei Tongji Hospital, Huazhong University of Science and Technology Recruiting Wuhan, Hubei, China, 430030 Contact: Yi-ping Wu, M.D.    +86 27 62363420    mail@tjh.tjmu.edu.cn    Principal Investigator: Yi-ping Wu, M.D.          China, Jiangsu Nanjing General Hospital of Nanjing Military Command Recruiting Nanjing, Jiangsu, China, 210002 Contact: Zhi-wei Jiang, M.D.    +86 25 84619727    surgery34@163.com    Principal Investigator: Zhi-wei Jiang, M.D.          China, Shanghai Xin Hua Hospital, Shanghai Jiaotong University Recruiting Shanghai, Shanghai, China, 200029 Contact: Wei Cai, M.D.    +86 21 65790000    caiwei204@yahoo.com.cn    Principal Investigator: Wei Cai, M.D.          Sixth Hospital Recruiting Shanghai, Shanghai, China Contact: Huai-Long Qin, M.D.       hlqin@sjtu.edu.cn    Sub-Investigator: Huai-Long Qin, M.D.          China, Xinjiang The First Affiliated Hospital, Xinjiang Medical University Active, not recruiting Urumqi, Xinjiang, China, 830054 China, Zhejiang Second Affiliated Hospital, Zhejiang University Active, not recruiting Hangzhou, Zhejiang, China, 310006 Less <<
NCT02798120 Acne Vulgaris Phase 3 Completed - -
NCT03705507 Acute Lymphoblastic Leukemia ... More >> Acute Lymphoblastic Leukemia, Adult Acute Lymphoblastic Leukemia, Pediatric Acute Lymphoblastic Leukemia, in Relapse Acute Lymphoblastic Leukemia Recurrent Less << Phase 1 Phase 2 Recruiting March 17, 2021 United Kingdom ... More >> Birmingham Children's Hospital Recruiting Birmingham, United Kingdom Principal Investigator: Alice Norton          Alder Hey Children's Hospital Recruiting Liverpool, United Kingdom Principal Investigator: Mark Caswell          Department of Paediatric Oncology, Royal Marsden Hospital, Sutton Recruiting London Borough of Sutton, United Kingdom Principal Investigator: Donna Lancaster          Haemato-Oncology Adult Unit, Royal Marsden Hospital, Sutton Recruiting London Borough of Sutton, United Kingdom Sub-Investigator: David Taussig          University College Hospital Recruiting London, United Kingdom Principal Investigator: Adele Fielding          The Christie Hospital Recruiting Manchester, United Kingdom Principal Investigator: Anna Castleton          Freeman Hospital Recruiting Newcastle, United Kingdom Sub-Investigator: Tobias Menne          Great North Children's Hospital, Royal Victoria Infirmary Recruiting Newcastle, United Kingdom Principal Investigator: Geoff Shenton Less <<
NCT02672332 Acne Vulgaris Phase 3 Completed - -
NCT03721718 Healthy Phase 1 Phase 2 Recruiting November 2020 Korea, Republic of ... More >> Seoul National University Bundang Hospital Recruiting Seongnam, Korea, Republic of Contact: Eu Suk Kim, MD, PhD    82-31-787-7062    eskim@snubh.org    Seoul National University Hospital Recruiting Seoul, Korea, Republic of Contact: Myoung-don Oh, MD, PhD    82-2-2072-2945    mdohmd@snu.ac.kr Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.26mL

0.65mL

0.33mL

16.32mL

3.26mL

1.63mL

32.65mL

6.53mL

3.26mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories